The active ingredient madecassoside in Huyan no. 1 formula ameliorates D-gal-induced renal aging through the AMPK/MAPK/AP-1 signaling pathway.

BACKGROUND

Renal aging accelerates overall organismal aging. The traditional Chinese medicine formula Huyan I (HY-1) has been shown to slow the decline in kidney function, but its pharmacological mechanism is unclear. This study focuses on its active component, madecassoside (MA), aiming to elucidate how it delays renal aging.

METHODS

HY-1 was evaluated in a D-galactose-induced mouse model using renal functional, histopathological, inflammatory, and molecular assessments. Serum-absorbed constituents were characterized by UHPLC-MS/MS and analyzed using network pharmacology, molecular docking, MM/GBSA binding free-energy calculations, and molecular dynamics simulations. The anti-senescent effects of madecassoside (MA) were validated in vivo and in D-galactose-treated HK-2 cells. Transcriptomic sequencing and pharmacological pathway modulation were used to investigate the involvement and hierarchical relationship of the AMPK and MAPK/AP-1 signaling axes.

RESULTS

Both HY-1 and MA ameliorated renal pathological injury, improved the expression levels of aging-related proteins (p53, p21, p16), promoted AMPK phosphorylation, and reduced senescence-associated secretory phenotype (SASP) factors (IL-1β, IL-6, TNF-α) in mouse serum, thereby slowing overall aging. MA also reduced intracellular peroxide accumulation in HK-2 cells, restored mitochondrial membrane potential, and improved mitochondrial function. Transcriptomic analysis revealed that MA may exert anti-aging effects by suppressing the MAPK signaling pathway (inhibiting phosphorylation of p38, ERK, JNK) and reducing nuclear phosphorylation of c-Fos and c-Jun, affecting AP-1 transcription factor formation. When AMPK phosphorylation was inhibited, MA's anti-aging effect was abrogated, and MAPK pathway activation was enhanced.

CONCLUSION

As the one of the principal active ingredients of HY-1, MA delays renal aging by promoting AMPK phosphorylation to maintain mitochondrial function and reduce peroxide accumulation, while inhibiting the MAPK signaling pathway to decrease AP-1 transcription factor synthesis.